Skip to main content
Top
Published in: Cancer Causes & Control 3/2006

01-04-2006 | Original Paper

Non-Cancer Mortality among People Diagnosed with Cancer (Australia)

Authors: Peter D. Baade, Lin Fritschi, Elizabeth G. Eakin

Published in: Cancer Causes & Control | Issue 3/2006

Login to get access

Abstract

Objective

To investigate whether people diagnosed with cancer have an increased risk of death from non-cancer causes compared to the general population.

Methods

The non-cancer mortality of people diagnosed with cancer in Queensland (Australia) between 1982 and 2002 who had not died before 1 January 1993 was compared to the mortality of the total Queensland population, matching by age group and sex, and reporting by standardised mortality ratios.

Results

Compared to the non-cancer mortality in the general population, cancer patients (all cancers combined) were nearly 50% more likely to die of non-cancer causes (SMR = 149.9, 95% CI = [147–153]). This varied by cancer site. Overall melanoma patients had significantly lower non-cancer mortality, female breast cancer patients had similar non-cancer mortality to the general population, while increased non-cancer mortality risks were observed for people diagnosed with cervical cancer, colorectal cancer, prostate cancer, non-Hodgkin lymphoma and lung cancer.

Conclusions

Although cancer-specific death rates underestimate the mortality directly associated with a diagnosis of cancer, quantifying the degree of underestimation is difficult due to various competing explanations. There remains an important role for future research in understanding the causes of morbidity among cancer survivors, particularly those looking at both co-morbid illnesses and reductions in quality of life.
Literature
1.
go back to reference Forman, D, Stockton, D, Moller, H, et al. 2003Cancer prevalence in the UK: results from the EUROPREVAL studyAnn Oncol14648654CrossRefPubMed Forman, D, Stockton, D, Moller, H,  et al. 2003Cancer prevalence in the UK: results from the EUROPREVAL studyAnn Oncol14648654CrossRefPubMed
2.
go back to reference Lutz, JM, Francisci, S, Mugno, E, et al. 2003Cancer prevalence in Central Europe: the EUROPREVAL StudyAnn Oncol14313322CrossRefPubMed Lutz, JM, Francisci, S, Mugno, E,  et al. 2003Cancer prevalence in Central Europe: the EUROPREVAL StudyAnn Oncol14313322CrossRefPubMed
3.
go back to reference Brameld, KJ, Holman, CDA, Threlfall, TJ, Lawrence, DM, Klerk, NH 2002Increasing ‘active prevalence’ of cancer in Western Australia and its implications for health servicesAust New Zeal J Public Health26164169 Brameld, KJ, Holman, CDA, Threlfall, TJ, Lawrence, DM, Klerk, NH 2002Increasing ‘active prevalence’ of cancer in Western Australia and its implications for health servicesAust New Zeal J Public Health26164169
4.
go back to reference MMWR2004Cancer Survivorship – United States, 1971–2001MMWR53526529 MMWR2004Cancer Survivorship – United States, 1971–2001MMWR53526529
5.
go back to reference Harkonen, PL, Makela, SI 2004Role of estrogens in development of prostate cancerJ Steroid Biochem Mol Biol92297305CrossRefPubMed Harkonen, PL, Makela, SI 2004Role of estrogens in development of prostate cancerJ Steroid Biochem Mol Biol92297305CrossRefPubMed
6.
go back to reference Mackey, JR, Joy, AA 2005Skeletal health in postmenopausal survivors of early breast cancerInt J Cancer11410101015CrossRefPubMed Mackey, JR, Joy, AA 2005Skeletal health in postmenopausal survivors of early breast cancerInt J Cancer11410101015CrossRefPubMed
7.
go back to reference Arber, N, Levin, B 2005Chemoprevention of colorectal cancer: ready for routine use?Recent Results Cancer Res166213230PubMed Arber, N, Levin, B 2005Chemoprevention of colorectal cancer: ready for routine use?Recent Results Cancer Res166213230PubMed
8.
go back to reference Bach, PB, Cramer, LD, Schrag, D, Downey, RJ, Gelfand, SE, Begg, CB 2001The influence of hospital volume on survival after resection for lung cancerN Engl J Med345181188CrossRefPubMed Bach, PB, Cramer, LD, Schrag, D, Downey, RJ, Gelfand, SE, Begg, CB 2001The influence of hospital volume on survival after resection for lung cancerN Engl J Med345181188CrossRefPubMed
9.
go back to reference Longo, WE, Virgo, KS, Johnson, FE, et al. 2000Risk factors for morbidity and mortality after colectomy for colon cancerDis Colon Rectum438391CrossRefPubMed Longo, WE, Virgo, KS, Johnson, FE,  et al. 2000Risk factors for morbidity and mortality after colectomy for colon cancerDis Colon Rectum438391CrossRefPubMed
10.
go back to reference Ezzati, M, Lopez, AD 2004Regional, disease specific patterns of smoking-attributable mortality in 2000Tob Control13388395PubMed Ezzati, M, Lopez, AD 2004Regional, disease specific patterns of smoking-attributable mortality in 2000Tob Control13388395PubMed
11.
go back to reference Ezzati, M, Lopez, AD 2003Estimates of global mortality attributable to smoking in 2000Lancet362847852PubMed Ezzati, M, Lopez, AD 2003Estimates of global mortality attributable to smoking in 2000Lancet362847852PubMed
12.
go back to reference Rashid, MN, Fuentes, F, Touchon, RC, Wehner, PS 2003Obesity and the risk for cardiovascular diseasePrev Cardiol64247PubMed Rashid, MN, Fuentes, F, Touchon, RC, Wehner, PS 2003Obesity and the risk for cardiovascular diseasePrev Cardiol64247PubMed
13.
go back to reference Oguma, Y, Shinoda Tagawa, T 2004Physical activity decreases cardiovascular disease risk in women: review and meta-analysisAm J Prev Med26407418CrossRefPubMed Oguma, Y, Shinoda Tagawa, T 2004Physical activity decreases cardiovascular disease risk in women: review and meta-analysisAm J Prev Med26407418CrossRefPubMed
14.
go back to reference Paffenbarger, RS,Jr, Blair, SN, Lee, IM 2001A history of physical activity, cardiovascular health and longevity: the scientific contributions of Jeremy N Morris, DSc, DPH, FRCPInt J Epidemiol3011841192CrossRefPubMed Paffenbarger, RS,Jr, Blair, SN, Lee, IM 2001A history of physical activity, cardiovascular health and longevity: the scientific contributions of Jeremy N Morris, DSc, DPH, FRCPInt J Epidemiol3011841192CrossRefPubMed
15.
go back to reference Hudson, MM, Mertens, AC, Yasui, Y, et al. 2003Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor StudyJAMA29015831592CrossRefPubMed Hudson, MM, Mertens, AC, Yasui, Y,  et al. 2003Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor StudyJAMA29015831592CrossRefPubMed
16.
go back to reference Oeffinger, KC, Hudson, MM 2004Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivorsCA Cancer J Clin54208236PubMed Oeffinger, KC, Hudson, MM 2004Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivorsCA Cancer J Clin54208236PubMed
17.
go back to reference Robison, LL, Mertens, AC, Boice, JD, et al. 2002Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative projectMed Pediatr Oncol38229239CrossRefPubMed Robison, LL, Mertens, AC, Boice, JD,  et al. 2002Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative projectMed Pediatr Oncol38229239CrossRefPubMed
18.
go back to reference Cardous Ubbink, MC, Heinen, RC, Langeveld, NE, et al. 2004Long-term cause-specific mortality among five-year survivors of childhood cancerPediatr Blood Cancer42563573PubMed Cardous Ubbink, MC, Heinen, RC, Langeveld, NE,  et al. 2004Long-term cause-specific mortality among five-year survivors of childhood cancerPediatr Blood Cancer42563573PubMed
19.
go back to reference Green, DM, Hyland, A, Chung, CS, Zevon, MA, Hall, BC 1999Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescenceJ Clin Oncol1732073215PubMed Green, DM, Hyland, A, Chung, CS, Zevon, MA, Hall, BC 1999Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescenceJ Clin Oncol1732073215PubMed
20.
go back to reference Mertens, AC, Yasui, Y, Neglia, JP, et al. 2001Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor StudyJ Clin Oncol1931633172PubMed Mertens, AC, Yasui, Y, Neglia, JP,  et al. 2001Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor StudyJ Clin Oncol1931633172PubMed
21.
go back to reference Brown, BW, Brauner, C, Minnotte, MC 1993Noncancer deaths in white adult cancer patientsJ Nat Cancer Inst85979987PubMed Brown, BW, Brauner, C, Minnotte, MC 1993Noncancer deaths in white adult cancer patientsJ Nat Cancer Inst85979987PubMed
22.
go back to reference Meraney, AM, Haese, A, Palisaar, J, et al. 2005Surgical management of prostate cancer: advances based on a rational approach to the dataEur J Cancer41888907CrossRefPubMed Meraney, AM, Haese, A, Palisaar, J,  et al. 2005Surgical management of prostate cancer: advances based on a rational approach to the dataEur J Cancer41888907CrossRefPubMed
23.
go back to reference Mangar, SA, Huddart, RA, Parker, CC, Dearnaley, DP, Khoo, VS, Horwich, A 2005Technological advances in radiotherapy for the treatment of localised prostate cancerEur J Cancer41908921CrossRefPubMed Mangar, SA, Huddart, RA, Parker, CC, Dearnaley, DP, Khoo, VS, Horwich, A 2005Technological advances in radiotherapy for the treatment of localised prostate cancerEur J Cancer41908921CrossRefPubMed
24.
go back to reference Bonomi, PD 2004Therapeutic advances in second-line treatment of advanced non-small-cell lung cancerClin Lung Cancer6154161PubMed Bonomi, PD 2004Therapeutic advances in second-line treatment of advanced non-small-cell lung cancerClin Lung Cancer6154161PubMed
25.
go back to reference Mincey, BA, Perez, EA 2004Advances in screening, diagnosis, and treatment of breast cancerMayo Clin Proc79810816PubMed Mincey, BA, Perez, EA 2004Advances in screening, diagnosis, and treatment of breast cancerMayo Clin Proc79810816PubMed
26.
go back to reference Faivre Finn, C, Bouvier Benhamiche, AM, Phelip, JM, Manfredi, S, Dancourt, V, Faivre, J 2002Colon cancer in France: evidence for improvement in management and survivalGut516064PubMed Faivre Finn, C, Bouvier Benhamiche, AM, Phelip, JM, Manfredi, S, Dancourt, V, Faivre, J 2002Colon cancer in France: evidence for improvement in management and survivalGut516064PubMed
27.
go back to reference White, V, Hill, D, Siahpush, M, Bobevski, I 2003How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001Tob Control12ii6774PubMed White, V, Hill, D, Siahpush, M, Bobevski, I 2003How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001Tob Control12ii6774PubMed
28.
go back to reference Molarius, A, Parsons, RW, Dobson, AJ, et al. 2001Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA ProjectAm J Public Health91206212PubMed Molarius, A, Parsons, RW, Dobson, AJ,  et al. 2001Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA ProjectAm J Public Health91206212PubMed
29.
go back to reference Zhang, Q, Wang, Y 2004Trends in the association between obesity and socioeconomic status in U.S. adults: 1971 to 2000Obes Res.1216221632PubMed Zhang, Q, Wang, Y 2004Trends in the association between obesity and socioeconomic status in U.S. adults: 1971 to 2000Obes Res.1216221632PubMed
30.
go back to reference Bauman, A, Armstrong, T, Davies, J, et al. 2003Trends in physical activity participation and the impact of integrated campaigns among Australian adults, 1997–99Aust N Z J Public Health277679PubMed Bauman, A, Armstrong, T, Davies, J,  et al. 2003Trends in physical activity participation and the impact of integrated campaigns among Australian adults, 1997–99Aust N Z J Public Health277679PubMed
31.
go back to reference Craig, CL, Russell, SJ, Cameron, C, Bauman, A 2004Twenty-year trends in physical activity among Canadian adultsCan J Public Health955963PubMed Craig, CL, Russell, SJ, Cameron, C, Bauman, A 2004Twenty-year trends in physical activity among Canadian adultsCan J Public Health955963PubMed
33.
go back to reference ABS (2005) Causes of Death 2003 [Appendix Comparability of data over time]. Canberra, Australian Bureau of Statistics (Catalogue number 3303.0) (www.abs.gov.au) ABS (2005) Causes of Death 2003 [Appendix Comparability of data over time]. Canberra, Australian Bureau of Statistics (Catalogue number 3303.0) (www.abs.gov.au)
34.
go back to reference Grulich, AE, Swerdlow, A, dos Santos Silva, I, Beral, V 1995Is the apparent rise in cancer mortality in the elderly real? Analysis of changes in certification and coding of cause of death in England and Wales, 1970–1990Int J Cancer63164168PubMed Grulich, AE, Swerdlow, A, dos Santos Silva, I, Beral, V 1995Is the apparent rise in cancer mortality in the elderly real? Analysis of changes in certification and coding of cause of death in England and Wales, 1970–1990Int J Cancer63164168PubMed
37.
go back to reference SAS Institute Inc (2004) SAS OnlineDoc®, Version 9.1.2. Cary NC, SAS Institute Inc SAS Institute Inc (2004) SAS OnlineDoc®, Version 9.1.2. Cary NC, SAS Institute Inc
38.
go back to reference ABS (2004) Causes of Death (various years). Canberra, Australian Bureau of Statistics (Catalogue number 3303.0) (www.abs.gov.au) ABS (2004) Causes of Death (various years). Canberra, Australian Bureau of Statistics (Catalogue number 3303.0) (www.abs.gov.au)
39.
go back to reference Coebergh, JW, Janssen-Heijnen, ML, Post, PN, Razenberg, PP 1999Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996J Clin Epidemiol5211311136CrossRefPubMed Coebergh, JW, Janssen-Heijnen, ML, Post, PN, Razenberg, PP 1999Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of The Netherlands in 1993–1996J Clin Epidemiol5211311136CrossRefPubMed
40.
go back to reference Janssen-Heijnen, ML, Schipper, RM, Razenberg, PP, Crommelin, MA, Coebergh, JW 1998Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based studyLung Cancer21105113CrossRefPubMed Janssen-Heijnen, ML, Schipper, RM, Razenberg, PP, Crommelin, MA, Coebergh, JW 1998Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based studyLung Cancer21105113CrossRefPubMed
41.
go back to reference Spronsen, DJ, Janssen-Heijnen, ML, Breed, WP, Coebergh, JW 1999Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin’s disease and non-Hodgkin’s lymphoma, 1993–1996Annals Hematol78315319 Spronsen, DJ, Janssen-Heijnen, ML, Breed, WP, Coebergh, JW 1999Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin’s disease and non-Hodgkin’s lymphoma, 1993–1996Annals Hematol78315319
42.
go back to reference Hall, WH, Jani, AB, Ryu, JK, Narayan, S, Vijayakumar, S 2005The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancerProstate Cancer Prostatic Dis82230CrossRefPubMed Hall, WH, Jani, AB, Ryu, JK, Narayan, S, Vijayakumar, S 2005The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancerProstate Cancer Prostatic Dis82230CrossRefPubMed
43.
go back to reference Freedman, DM, Travis, LB, Gridley, G, Kuncl, RW 2005Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivorsNeuroepidemiology25176180PubMed Freedman, DM, Travis, LB, Gridley, G, Kuncl, RW 2005Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivorsNeuroepidemiology25176180PubMed
44.
go back to reference Harrison, RA, Haque, AU, Roseman, JM, Soong, SJ 1998Socioeconomic characteristics and melanoma incidenceAnn Epidemiol8327333CrossRefPubMed Harrison, RA, Haque, AU, Roseman, JM, Soong, SJ 1998Socioeconomic characteristics and melanoma incidenceAnn Epidemiol8327333CrossRefPubMed
46.
go back to reference Coory M, Baade PD, Aitken JF, Smithers M, McLeod GRC, Ring I (in press) Trends for in-situ and invasive melanoma in Queensland, Australia, 1982 to 2002. Cancer Causes and Control 17:21–27 Coory M, Baade PD, Aitken JF, Smithers M, McLeod GRC, Ring I (in press) Trends for in-situ and invasive melanoma in Queensland, Australia, 1982 to 2002. Cancer Causes and Control 17:21–27
47.
go back to reference Gordon, NH 2003Socioeconomic factors and breast cancer in black and white AmericansCancer Metastasis Rev225565CrossRefPubMed Gordon, NH 2003Socioeconomic factors and breast cancer in black and white AmericansCancer Metastasis Rev225565CrossRefPubMed
49.
go back to reference Ridolfo B, Stevenson C (2001) The quantification of drug-caused mortality and morbidity in Australia, 1998. Canberra, Australian Institute of Health and Welfare. AIHW Cat. No. PHE 29 Ridolfo B, Stevenson C (2001) The quantification of drug-caused mortality and morbidity in Australia, 1998. Canberra, Australian Institute of Health and Welfare. AIHW Cat. No. PHE 29
50.
go back to reference Barbeau, EM, Krieger, N, Soobader, MJ 2004Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000Am J Public Health94269278PubMed Barbeau, EM, Krieger, N, Soobader, MJ 2004Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000Am J Public Health94269278PubMed
Metadata
Title
Non-Cancer Mortality among People Diagnosed with Cancer (Australia)
Authors
Peter D. Baade
Lin Fritschi
Elizabeth G. Eakin
Publication date
01-04-2006
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 3/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0530-0

Other articles of this Issue 3/2006

Cancer Causes & Control 3/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine